Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adolescence Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures

计划入组 519 人 · 首次发布于 2017 年 2 月 23 日

Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adult Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures

计划入组 3,809 人 · 首次发布于 2017 年 2 月 23 日

A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures

计划入组 64 人 · 首次发布于 2006 年 2 月 16 日

C5 inhibitor (oral, generalized myasthenia gravis)

Perampanel(Fycompa)

C₂₃H₁₅N₃O · Rx

Fosphenytoin(Cerebyx, Sesquient)

C₁₆H₁₅N₂O₆P

Ridgestone Mining Inc

United States

Cornerstone Total Return Fund Inc

iShares Core Composite Bond ETF

United States

Japan Approves Ono's XCOPRI (Cenobamate) for Partial-Onset Seizures After Phase 3 Win

South Korea Approves First Epilepsy Drug Under New Fast-Track Review Process

Lacosamide Evaluated for Efficacy in Idiopathic Generalized Epilepsy Patients